Scott Eggener

Great study. Need more of these My kinda sorta version of this: "try tamsulosin for a few weeks; if it isn't helping, stop it" Tamsulosin Deprescribing for Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men jamanetwork.com/journals/jaman…

Yet another reminder that thoughtful PrCa screening, risk-based management, and equal access can have tremendous value for individual and population health The more we minimize overDx and overRx, the more men will be screened and have their lives saved jamanetwork.com/journals/jamao…

This will definitely stimulate some debate....and should Surgeon Sleep Patterns and Patient Risk of Major Adverse Events jamanetwork.com/journals/jamas…

First ever locally injectable immunoactive agent with proven DFS benefit in localized prostate cancer. Tandem randomized Phase II in surveillance forthcoming. Origin: Baylor basic science lab (support research!) thelancet.com/journals/lanon…

The Influence of Urology on Longevity JAMA article from 1926: vaccines, clean water, and Urology (?!?!) responsible for dramatic lengthening of life expectancy jamanetwork.com/journals/jama/…

@TylerSbrt @HardenedBeam @DrYukselUrun @JAMAOnc @APCCC_Lugano @VickersBiostats @dr_coops @OncoAlert @OpenMedicineHQ @MedwatchKate @GGiannarini @yekeduz_emre @neerajaiims @Silke_Gillessen @CParkMD @dmukherji @nataliagandur @scserendipity1 @sumersethi Perhaps that will change, COMET trial RCT: jamanetwork.com/journals/jama/…

@HardenedBeam @DrYukselUrun @JAMAOnc @APCCC_Lugano @VickersBiostats @dr_coops @uroegg @OncoAlert @OpenMedicineHQ @MedwatchKate @GGiannarini @yekeduz_emre @neerajaiims @Silke_Gillessen @CParkMD @dmukherji @nataliagandur @scserendipity1 @sumersethi This worries me, too

What if removing the word "cancer" could save more lives than it risks? Some words may carry more weight than the disease itself. @JAMAOnc @APCCC_Lugano @VickersBiostats @dr_coops @uroegg @OncoAlert @OpenMedicineHQ @MedwatchKate

@DrSpratticus @OtisBrawley @dr_coops @VickersBiostats @GladellPaner @UCLAHealth @UCLAHealthJCCC We've made progress in AS rates but took too long and still work to do. I remain troubled by the rate of GG1 patients undergoing any treatment. I occasionally do but it's rare. As convinced as ever: nomenclature change for GG1 would be a meaningful win for public health

Scott- very nice paper. Curious how you reconcile the number one use of focal tx in the USA (paper under review) in USA is in low risk. As there is no ability to improve oncologic outcomes it is only providing harm. We saw after AS rates reduced RP in low risk it was near completely associated with an increase in RP in high risk. Did the authors model the impact if they now do focal to intermediate and high risk, the very high recurrence risk and concerns for even metastatic risk?

It's entirely plausible that renaming Grade Group 1 (Gleason 6) PrCa can save a whole lot of lives. Consider reading and discussing. Editorial by @OtisBrawley @dr_coops @VickersBiostats @GladellPaner @UCLAHealth @UCLAHealthJCCC jamanetwork.com/journals/jamao…

Exhibit A: jamanetwork.com/journals/jaman…

Makes me sad. RCT's are essential to help individuals and improve public health. Clinician-scientists (and others) have work to do to fix this divide. Clinical Trial Skepticism and Political Ideology Among US Adults and Cancer Survivors jamanetwork.com/journals/jaman…

Release the hounds...... Minimally Invasive Surgery, Intraoperative Capsule Rupture, and Survival in Early Ovarian Cancer jamanetwork.com/journals/jamao…

@docbagaria Great point, surprisingly high hernia rates in both arms

@uroegg Are these hernia rates acceptable in elective laparotomy?

For those of us who still do some laparotomies. Small vs Large Bites for Abdominal Midline Incisions jamanetwork.com/journals/jamas…

@daviesbj @CanesDavid Doing the right thing isn't always the quickest thing

@CanesDavid @uroegg this just increased the OR time across our enterprise

Cheap, easy, and reliable for ADT-induced hot flashes: oxybutynin for the win!! Dries up perspiration and the mouth. ascopubs.org/doi/10.1200/JC…

Whoa.....what's old is new again! Transdermal Estradiol Patches in Locally Advanced Prostate Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…

The @UCLAHealth Urology Spring 2026 newsletter is out. Take a look at program highlights, alumni profiles, and update from the chair. uclahealth.org/sites/default/…

@DrSpratticus @ChapinMD @urotoday @UroOnc @Uroweb @wandering_gu @BogdanaSchmidt @CanesDavid @DrMLChua @HimanshuNagarMD @AmarUKishan @piet_ost @alison_tree @declangmurphy Highest value (by far) is estimating prostate size (PSAD) in order to risk stratify whether they even need MRI, secondary biomarker, or biopsy. And do occasionally find induration/nodule that is potentially meaningful

#EAU26 DRE not recommended for asymptomatic men. What are people’s thoughts on need for routine DRE in era of MRI? @ChapinMD @urotoday @UroOnc @Uroweb @wandering_gu @BogdanaSchmidt @CanesDavid @DrMLChua @HimanshuNagarMD @AmarUKishan @piet_ost @alison_tree @declangmurphy

Prof Hugosson: Göteborg trial with 30 year outcomes! NND falls to -6-, with greatest benefit for men 50-59 at randomization. Despite no image guidance, high overdx, and suboptimal tx. Best evidence we have re: the evidence for #prostatecancer screening. Get tested! #eau26 @uroweb

A cancer diagnosis can push people to crime economist.com/graphic-detail… from The Economist